跳至主要内容
临床试验/NCT04171349
NCT04171349已完成早期 1 期

Articaine and Dexmedetomidine - Supplemented Articaine for Arteriovenous Fistula Creation Under Ultrasound- Guided Supraclavicular Block

Ain Shams University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
50
试验地点
1
主要终点
Duration of sensory block

研究概览

简要总结

The aim of this study to test efficacy of adding dexmedetomidine to articaine on sensory, motor and duration of analgesia during hemodialysis fistula creation under ultrasound guided supraclavicular block

详细描述

Adult fifty patient with chronic renal failure on hemodialysis, scheduled for arteriovenous fistula creation under ultrasound guided supraclavicular block. Patients were randomly allocated in two group. The articaine group (group A) received 40 ml articaine hydrochloride 2% and articaine-dexmedetomidine group (group AD) received 40 ml. Of articaine 2% mixed with dexmedetomidine (1micogram/kg)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
25 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adult patient with chronic renal failure on hemodialysis scheduled for radiocephalic fistula creation

排除标准

  • Allergy to local anesthetics.
  • Infection at the site of needle insertion.
  • Those having international normalized ratio more than 1.
  • Coagulopathy.
  • Neuromuscular, or severe hepatic or severe pulmonary disease.
  • Those having epilepsy.
  • Patients who refused to participate.

研究组 & 干预措施

Group A

Active Comparator

Patients received ultrasound guided supraclavicular block with 40 ml of Articaine hydrochloride 2%

干预措施: Articaine (Drug)

Group AD

Experimental

Patients received ultrasound guided supraclavicular block with 40 ml articaine 2% mixed with dexmedetomidine (1 µg/kg).

干预措施: Articaine (Drug)

Group AD

Experimental

Patients received ultrasound guided supraclavicular block with 40 ml articaine 2% mixed with dexmedetomidine (1 µg/kg).

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Duration of sensory block

时间窗: 24 hours

Sensory block time tested by pinprick test measured in minute

Duration of motor block

时间窗: 24 hours

Motor block time tested by Bromage scale measured in minutes

次要结局

  • Duration of analgesia(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

simon Halim Armanious

Simon Halim, MD S. Armanious

Ain Shams University

研究点 (1)

Loading locations...

相似试验